DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
ImmunityBio, Inc.
Mayo Clinic
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Tasly Biopharmaceuticals Co., Ltd.
Exelixis
ImmunoVaccine Technologies, Inc. (IMV Inc.)
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)